Terms: = Pancreatic cancer AND KRAS, C-K-RAS, 3845, P01116, NS3, KI-RAS, KRAS2, K-RAS4A, K-RAS2A, K-RAS4B, KRAS1, K-RAS2B, RASK2 AND Staging
34 results:
1. Advancements and perspectives of RBX2 as a molecular hallmark in cancer.
Tao Y; Dai L; Liang W; Li X; Lyu Y; Li J; Li Z; Shi Z; Liang X; Zhou S; Fu X; Hu W; Wang X
Gene; 2024 Jan; 892():147864. PubMed ID: 37820940
[TBL] [Abstract] [Full Text] [Related]
2. Relationship between circulating tumour DNA and skeletal muscle stores at diagnosis of pancreatic ductal adenocarcinoma: a cross-sectional study.
Hanna L; Sellahewa R; Huggins CE; Lundy J; Croagh D
Sci Rep; 2023 Jun; 13(1):9663. PubMed ID: 37316578
[TBL] [Abstract] [Full Text] [Related]
3. Multimodal survival prediction in advanced pancreatic cancer using machine learning.
Keyl J; Kasper S; Wiesweg M; Götze J; Schönrock M; Sinn M; Berger A; Nasca E; Kostbade K; Schumacher B; Markus P; Albers D; Treckmann J; Schmid KW; Schildhaus HU; Siveke JT; Schuler M; Kleesiek J
ESMO Open; 2022 Oct; 7(5):100555. PubMed ID: 35988455
[TBL] [Abstract] [Full Text] [Related]
4. Evaluation of circulating cell-free kras mutational status as a molecular monitoring tool in patients with pancreatic cancer.
Schlick K; Markus S; Huemer F; Ratzinger L; Zaborsky N; Clemens H; Neureiter D; Neumayer B; Beate AS; Florian S; Martin V; Grundbichler M; Weiss L; Melchardt T; Greil R; Egle A
Pancreatology; 2021 Dec; 21(8):1466-1471. PubMed ID: 34511398
[TBL] [Abstract] [Full Text] [Related]
5. Molecular Peritoneal staging for pancreatic Ductal Adenocarcinoma Using Mutant kras Droplet-Digital Polymerase Chain Reaction: Results of a Prospective Clinical Trial.
Yonkus JA; Alva-Ruiz R; Abdelrahman AM; Leiting JL; Schneider AR; Grotz TE; Cleary SP; Smoot RL; Nagorney DM; Kendrick ML; Kipp BR; Truty MJ
J Am Coll Surg; 2021 Jul; 233(1):73-80.e1. PubMed ID: 34022414
[TBL] [Abstract] [Full Text] [Related]
6. The Unmet Needs of the Diagnosis, staging, and Treatment of Gastrointestinal Tumors.
Halama N; Haberkorn U
Semin Nucl Med; 2020 Sep; 50(5):389-398. PubMed ID: 32768003
[TBL] [Abstract] [Full Text] [Related]
7. A Multianalyte Panel Consisting of Extracellular Vesicle miRNAs and mRNAs, cfDNA, and CA19-9 Shows Utility for Diagnosis and staging of pancreatic Ductal Adenocarcinoma.
Yang Z; LaRiviere MJ; Ko J; Till JE; Christensen T; Yee SS; Black TA; Tien K; Lin A; Shen H; Bhagwat N; Herman D; Adallah A; O'Hara MH; Vollmer CM; Katona BW; Stanger BZ; Issadore D; Carpenter EL
Clin Cancer Res; 2020 Jul; 26(13):3248-3258. PubMed ID: 32299821
[TBL] [Abstract] [Full Text] [Related]
8. Lymphatic vessel remodeling and invasion in pancreatic cancer progression.
Shen CN; Goh KS; Huang CR; Chiang TC; Lee CY; Jeng YM; Peng SJ; Chien HJ; Chung MH; Chou YH; Hsieh CC; Kulkarni S; Pasricha PJ; Tien YW; Tang SC
EBioMedicine; 2019 Sep; 47():98-113. PubMed ID: 31495721
[TBL] [Abstract] [Full Text] [Related]
9. Genetic Changes of P
Shukla SK; Singh G; Shahi KS; Bhuvan ; Pant P
J Gastrointest Cancer; 2020 Jun; 51(2):552-559. PubMed ID: 31396884
[TBL] [Abstract] [Full Text] [Related]
10. Glucose metabolism during tumorigenesis in the genetic mouse model of pancreatic cancer.
Pasquale V; Dugnani E; Liberati D; Marra P; Citro A; Canu T; Policardi M; Valla L; Esposito A; Piemonti L
Acta Diabetol; 2019 Sep; 56(9):1013-1022. PubMed ID: 30989379
[TBL] [Abstract] [Full Text] [Related]
11. Expression of miRNA-143 in pancreatic cancer and Its Clinical Significance.
Xu B; Liu J; Xiang X; Liu S; Zhong P; Xie F; Mou T; Lai L
Cancer Biother Radiopharm; 2018 Nov; 33(9):373-379. PubMed ID: 30004802
[TBL] [Abstract] [Full Text] [Related]
12. The Evolving Role of Pathology in New Developments, Classification, Terminology, and Diagnosis of Pancreatobiliary Neoplasms.
Reid MD; Lewis MM; Willingham FF; Adsay NV
Arch Pathol Lab Med; 2017 Mar; 141(3):366-380. PubMed ID: 28055239
[TBL] [Abstract] [Full Text] [Related]
13. Circulating tumour cells as a biomarker for diagnosis and staging in pancreatic cancer.
Ankeny JS; Court CM; Hou S; Li Q; Song M; Wu D; Chen JF; Lee T; Lin M; Sho S; Rochefort MM; Girgis MD; Yao J; Wainberg ZA; Muthusamy VR; Watson RR; Donahue TR; Hines OJ; Reber HA; Graeber TG; Tseng HR; Tomlinson JS
Br J Cancer; 2016 Jun; 114(12):1367-75. PubMed ID: 27300108
[TBL] [Abstract] [Full Text] [Related]
14. Role of endoscopic ultrasound in the molecular diagnosis of pancreatic cancer.
Bournet B; Gayral M; Torrisani J; Selves J; Cordelier P; Buscail L
World J Gastroenterol; 2014 Aug; 20(31):10758-68. PubMed ID: 25152579
[TBL] [Abstract] [Full Text] [Related]
15. Applications of endoscopic ultrasound in pancreatic cancer.
Luz LP; Al-Haddad MA; Sey MS; DeWitt JM
World J Gastroenterol; 2014 Jun; 20(24):7808-18. PubMed ID: 24976719
[TBL] [Abstract] [Full Text] [Related]
16. Cetuximab therapy in the treatment of metastatic colorectal cancer: the future frontier?
Gomez D; De Rosa A; Addison A; Brooks A; Malik HZ; Cameron IC
Int J Surg; 2013; 11(7):507-13. PubMed ID: 23660586
[TBL] [Abstract] [Full Text] [Related]
17. Prognostic value of K-ras mutation status and subtypes in endoscopic ultrasound-guided fine-needle aspiration specimens from patients with unresectable pancreatic cancer.
Ogura T; Yamao K; Hara K; Mizuno N; Hijioka S; Imaoka H; Sawaki A; Niwa Y; Tajika M; Kondo S; Tanaka T; Shimizu Y; Bhatia V; Higuchi K; Hosoda W; Yatabe Y
J Gastroenterol; 2013 May; 48(5):640-6. PubMed ID: 22983505
[TBL] [Abstract] [Full Text] [Related]
18. Changing pathology with changing drugs: tumors of the gastrointestinal tract.
Cervera P; Fléjou JF
Pathobiology; 2011; 78(2):76-89. PubMed ID: 21677471
[TBL] [Abstract] [Full Text] [Related]
19. K-ras mutational status predicts poor prognosis in unresectable pancreatic cancer.
Chen H; Tu H; Meng ZQ; Chen Z; Wang P; Liu LM
Eur J Surg Oncol; 2010 Jul; 36(7):657-62. PubMed ID: 20542658
[TBL] [Abstract] [Full Text] [Related]
20. Gallbladder cancer: a morphological and molecular update.
Goldin RD; Roa JC
Histopathology; 2009 Aug; 55(2):218-29. PubMed ID: 19490172
[TBL] [Abstract] [Full Text] [Related]
[Next]